{"as_of":"2026-08-21T11:52:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:3e371661145cd87d933fd85e31a469a6b2f1185393dec516318028d5142fe0e9","coverage":[{"denominator":24,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":24,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-06T17:44:07.891769Z","state":"measured"},{"denominator":24,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":24,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-21T06:32:19.484+00:00","state":"measured"},{"denominator":0,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":0,"source":"paper_references, paper_reference_links","source_observed_at":null,"state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"cited_works","source_observed_at":null,"state":"measured"}],"external_citation_measurements":[],"inbound":[],"links":{"evidence":"/evidence","html":"/paper/2507.10269/citation-record","integrity":"/paper/2507.10269/integrity","json":"/paper/2507.10269/citation-record.json","paper":"/paper/2507.10269"},"outbound":[{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.406689Z","title":"M., Griger, Z., Moiseev, S., Oddis, C., Schiopu, E., Vencovsk \\`y , J., et al","venue":null,"work_id":"12ddd1c1-fa4b-4c3e-81c0-ae76cd4971a6","year":2022},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":1,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:06.398986Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:e982ca4be715004a94f7ab543ff736456cf94749ed59302729e0acd1480b13e4","observation_id":"6b50dce6-a608-430f-94d7-1b78cb686788","resolution":{"observed_at":"2026-08-06T17:44:08.413449Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.381840Z","title":null,"venue":null,"work_id":"bcf15249-8baf-4542-8f59-7da27cf2cf29","year":2007},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":2,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:06.533933Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:65a331c9ea1a31a57232bde948a6cfa70b282d8a8800bee3b683061283481d0c","observation_id":"2ee33f7d-8efe-406c-a343-c6330c6e4144","resolution":{"observed_at":"2026-08-06T17:44:08.388331Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.355927Z","title":"J., Cooper, C","venue":null,"work_id":"816ec737-3fbd-49c2-8fb5-09894ef62e9b","year":2010},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":3,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:06.655756Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:8dc90e00a7f7317577ca02092c76f2105ff2d1d34858839632276445c9a68f9c","observation_id":"991ae7ab-d1e9-43c5-93a2-1e7e264b4e24","resolution":{"observed_at":"2026-08-06T17:44:08.363451Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.326499Z","title":null,"venue":null,"work_id":"b2d7037e-02bd-48b1-bb78-5aafc63a9b6e","year":2021},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":4,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:06.765335Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:573a4eea7c514b700175726ec14d2450496c32c5431bc451fdb28cef4b81b34f","observation_id":"56fa36ff-6135-4a2e-a7ed-66d28b8206e4","resolution":{"observed_at":"2026-08-06T17:44:08.336819Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.305069Z","title":null,"venue":null,"work_id":"ef212843-dcb0-42f9-8ff2-ed3a685a6b9b","year":2023},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":5,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:06.897854Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:92f8f3a1ef1559c37dea53245ce867c199f6378d1035b60b6ec44e7acda20e0c","observation_id":"97c244f0-eacc-4e89-87a4-11d8618b0ca3","resolution":{"observed_at":"2026-08-06T17:44:08.310223Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.280284Z","title":null,"venue":null,"work_id":"a36006fc-4abd-4195-a3b2-d801787d36f4","year":2020},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":6,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:06.976814Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:d34a2a8c88ce8a25dd3c0ff8621576d049bb2ed31beff0e26f19691adc560bd7","observation_id":"afc16a89-374e-49ea-a059-6eb4df2882b6","resolution":{"observed_at":"2026-08-06T17:44:08.289072Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.257404Z","title":"M., Golchi, S., Hudson, M., and Hoa, S","venue":null,"work_id":"7fd63d16-5c66-4b52-bf2e-760df083ee8a","year":2024},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":7,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.028707Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:5e78f9368dfc885b8fea3c8eb4b128d05ffad2e3834ce0431ceabc08ede3eced","observation_id":"e0518bc9-4136-4c32-80b5-efca554cd85f","resolution":{"observed_at":"2026-08-06T17:44:08.262942Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.238436Z","title":null,"venue":null,"work_id":"2b86a3c1-2057-4f36-8659-8109b6588e78","year":2006},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":8,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.144469Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:4e14379c4c9e98278f1be0575c7e870af0a68c80407ac8075930e65f8a79c9a2","observation_id":"549c975a-8b5f-4ae7-a5f7-f0ef5c4239af","resolution":{"observed_at":"2026-08-06T17:44:08.243267Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.218896Z","title":null,"venue":null,"work_id":"f905907e-78f7-4ce6-a321-9f00f2e7102e","year":2019},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":9,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.195464Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:9c4187291ed022ac974fdd695e610d4c6690dca1bd360bab6cefc61519da6958","observation_id":"28b1a593-0882-488d-8099-44cac8a7169e","resolution":{"observed_at":"2026-08-06T17:44:08.226068Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.200286Z","title":null,"venue":null,"work_id":"f0cec2c4-ca75-4b7a-8e57-74474d6f0293","year":2010},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":10,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.280762Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:764ac68a8d9566f3c6ef88646207b5fe22a226d5705e81cf0ab0fe7c095545f0","observation_id":"84c97187-761f-4ee5-8f16-26a726b47b52","resolution":{"observed_at":"2026-08-06T17:44:08.205748Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.177349Z","title":"C., Batshaw, M., Dunkle, M., Gopal-Srivastava, R., Kaye, E., Krischer, J., Nguyen, T., Paulus, K., Merkel, P","venue":null,"work_id":"88d9468c-ecef-458c-8d86-78433cb64adb","year":2009},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":11,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.365723Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:f49941f52eb09626d1bb2a04fbeb13579086c9e9e751b5ed18739a856469f902","observation_id":"e380327e-32bd-4bc5-a07b-6a6199a5d613","resolution":{"observed_at":"2026-08-06T17:44:08.182733Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:07.487381Z","title":"P., Carlin, B","venue":null,"work_id":null,"year":2011},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":12,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.487381Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:a7d8941310dfb7afd21cdc3533efaba54ff98f36e5e0469106c34b26aeba1ddf","observation_id":"992974f6-ac1f-4635-aa14-9136eaa80b46","resolution":{"observed_at":"2026-08-06T17:44:07.487381Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.144081Z","title":null,"venue":null,"work_id":"133396ae-8fcc-4d50-a25c-689a6ef3bea0","year":2000},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":13,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.575874Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:79fff2a2fe717900413312545c1122ab0191a350d575a56d8cd10bfd67105c2d","observation_id":"879b1185-8b98-4d14-acd7-142047931168","resolution":{"observed_at":"2026-08-06T17:44:08.150150Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.125086Z","title":"Utilisation des immunoglobulines non spécifiques intraveineuses et sous-cutanées au québec, 2020-2021","venue":null,"work_id":"d5d20954-8486-4007-8301-2bbdbb81b518","year":2023},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":14,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.649695Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:fdd9c8531961a2391ed68bbe071158f49458fbf4b182d18d794214085f3c10da","observation_id":"8c86d9be-3b04-4113-af8e-ea7ad665073b","resolution":{"observed_at":"2026-08-06T17:44:08.130710Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.106523Z","title":"C., Davis, L","venue":null,"work_id":"193065c7-38b3-4153-927d-99b3ca1b9d54","year":2011},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":15,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.722491Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:b41eb72c11029a560788e3d430804ede268f624d89207a85d110cbda1c2e104f","observation_id":"9c3ab9ae-d20c-4f4a-9242-b91de163d443","resolution":{"observed_at":"2026-08-06T17:44:08.111100Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.089047Z","title":"E., Saris, C","venue":null,"work_id":"c34da44d-a922-48fc-a5e9-9f5b1450516c","year":2021},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":16,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.815011Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:d98cfff8cfab090f9e4a1334c3b5997cfdb14cc013a76ff41df467ee585f18bb","observation_id":"5706d18d-95af-4530-a0e2-62ae1d64c2d5","resolution":{"observed_at":"2026-08-06T17:44:08.093824Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.064926Z","title":null,"venue":null,"work_id":"bf7c830a-18ed-4aef-8ff6-da75c1796a00","year":2017},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":17,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.857401Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:e2e78845cc006dff2ca83be72e20ae099558979d9c1473030152a98139e75021","observation_id":"d46cf305-d604-499f-8299-248c6302f631","resolution":{"observed_at":"2026-08-06T17:44:08.070471Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.047743Z","title":null,"venue":null,"work_id":"0acc0d6e-8761-4488-86e9-f178708e5ac0","year":2019},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":18,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.862347Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:46e84ed2bb6f30f43a334fbfc2fe0a65fe50034cf7b54d66dcd23796036ca8e5","observation_id":"41d2fe8d-ff78-4d4f-9a3d-c7780b3912b5","resolution":{"observed_at":"2026-08-06T17:44:08.053001Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:08.023284Z","title":"V., and Wason, J","venue":null,"work_id":"4a8df743-2440-4e92-a3f3-0121ad9f3167","year":2022},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":19,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.867288Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:106bfffade6a8bc484e693790857a514f5d546b730cd983a87e3b3ae137a7573","observation_id":"48973637-7270-4329-9cd1-5d61b40490c0","resolution":{"observed_at":"2026-08-06T17:44:08.031632Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:07.871653Z","title":null,"venue":null,"work_id":null,"year":2014},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":20,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.871653Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:8eaecea29d4e8bc97606e334216072650858a0dc4072b19f05bb6e20b9a6abc7","observation_id":"69a9c033-939c-48d8-adc1-2601abbd7a1b","resolution":{"observed_at":"2026-08-06T17:44:07.871653Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2112.14616","last_updated":"2021-12-29T16:07:02Z","snapshot_observed_at":"2026-08-16T17:31:20.835765Z","submitted_at":"2021-12-29T16:07:02Z","title":"BayesPPD: An R Package for Bayesian Sample Size Determination Using the Power and Normalized Power Prior for Generalized Linear Models","version":1},"cited_work":{"arxiv_id":"2112.14616","doi":null,"metadata_source":"pith","pith_arxiv_id":"2112.14616","snapshot_observed_at":"2026-08-06T17:44:07.932192Z","title":"BayesPPD: An R Package for Bayesian Sample Size Determination Using the Power and Normalized Power Prior for Generalized Linear Models","venue":"stat.AP","work_id":"9e49420f-7423-41c8-807a-dcd498d2d226","year":2021},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":21,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.877337Z"},"links":{"cited_paper":"/paper/2112.14616","citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:8c1c62e461ffeda5c843a9d5f607cb0376842a7c46e0c96199135f6b1a37553e","observation_id":"0ddb533f-df4a-45d2-96a4-40fefc7c468b","resolution":{"observed_at":"2026-08-06T17:44:07.940096Z","resolver_source":"local_arxiv","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:07.989293Z","title":"P., Robson, R., Thabane, M., Giangregorio, L., and Goldsmith, C","venue":null,"work_id":"6e8edae8-8170-445d-bf2f-29f54f7a6ed2","year":2010},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":22,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.882377Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:a81a3fd98475d2e3bdb1e7e3066ed42e8336298149d6fb6e431e721a2bfbd8b8","observation_id":"9bc8529d-afc6-428b-84d9-705e9aefb661","resolution":{"observed_at":"2026-08-06T17:44:07.995302Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:07.969623Z","title":"Food and Drug Administration (2010)","venue":null,"work_id":"e65199a0-a2e4-4ecd-b80f-1e1faf3f233b","year":2010},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":23,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.887256Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:1168a7a0f3c6567a0a690fc1c28a025803f8203b2b514a443f9dd05fa1df09c4","observation_id":"09e36bb9-c51b-4923-b954-f5f46bb7e608","resolution":{"observed_at":"2026-08-06T17:44:07.974541Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T17:44:07.952544Z","title":null,"venue":null,"work_id":"08d1f5d7-0b1f-4136-8c1c-3bfe138f44f6","year":2021},"citing_paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods","version":1},"reference_index":24,"source":"arxiv_source","source_observed_at":"2026-08-06T17:44:07.891769Z"},"links":{"citing_paper":"/paper/2507.10269"},"observation_digest":"sha256:6268b4121906f908dccda8780803b2780d7a462a16f966023d584b52972ee432","observation_id":"db400220-8ff0-4a8e-90d0-bc4528e10a59","resolution":{"observed_at":"2026-08-06T17:44:07.957038Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-21T06:32:19.484+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"state":"measured"}}],"paper":{"arxiv_id":"2507.10269","last_updated":"2025-07-14T13:39:34Z","latest_version":1,"primary_category":"stat.AP","snapshot_observed_at":"2026-08-13T23:55:46.636448Z","submitted_at":"2025-07-14T13:39:34Z","title":"The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods"},"reference_resolution":{"displayed":24,"state_counts":{"malformed_identifier":0,"metadata_mismatch":0,"parse_uncertain":0,"unresolved":13,"verified_exact":1,"verified_fuzzy":10},"total_outbound_references":24},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-21T06:32:19.484+00:00","source":"crossref"},{"observed_at":"2026-08-21T06:32:16.066871+00:00","source":"retraction_watch"}],"thesis":"As of 21 August 2026, this Paper Citation Record lists 24 of 24 outbound references and 0 inbound Pith citation observations for arXiv:2507.10269."}